Literature DB >> 6264350

Familial spastic paraplegia, peroneal neuropathy, and crural hypopigmentation: a new neurocutaneous syndrome.

R M Stewart, G Tunell, A Ehle.   

Abstract

A neurocutaneous syndrome is described in which spastic paraplegia, peroneal neuropathy, and crural hypopigmentation are inherited in a dominant pattern. Spastic paraplegia becomes clinically apparent during adolescence or in childhood and progresses slowly throughout the adult years with a variability in severity of expression. Peroneal neuropathy is documented clinically and by slowing on nerve conduction studies. Pattern-reversal visual evoked potentials also yield a delayed response, but brainstem auditory evoked potentials and somatosensory evoked potentials in upper and lower extremities are normal. Crural hypopigmentation is present in each neurologically affected family member. Although the pattern may vary, a pretibial distribution predominates. The lower-extremity abnormalities of the central and peripheral nervous system and neural crest cell derivatives may share a common relationship, but the abnormal visual evoked potentials suggest a more generalized involvement. This family may represent a transition form between familial spastic paraplegia and the spinocerebellar degenerations.

Entities:  

Mesh:

Year:  1981        PMID: 6264350     DOI: 10.1212/wnl.31.6.754

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Familial spinocerebellar ataxia with skin hyperpigmentation.

Authors:  M Daras; A J Tuchman; S David
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-08       Impact factor: 10.154

2.  A study of posterior column function in familial spastic paraplegia.

Authors:  M R Dimitrijevic; J A Lenman; T Prevec; K Wheatly
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-01       Impact factor: 10.154

3.  A new phenotype linked to SPG27 and refinement of the critical region on chromosome.

Authors:  Pascale Ribai; Giovanni Stevanin; Naima Bouslam; Bénédicte Pontier; Isabelle Nelson; Bertrand Fontaine; Christel Dussert; Céline Charon; Alexandra Durr; Alexis Brice
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.